Study suggests a common brain network exists between heart rate deceleration and depression

Astellas Pharma Inc. has submitted a new drug application (NDA) to Japan’s Ministry of Health, Labour and Welfare (MHLW) for zolbetuximab. Zolbetuximab is a first-in-class

Republican candidates for president clashed over the future of the anti-abortion movement during Wednesday night’s primary debate in Miami — the day after key electoral

No­vo Nordisk is look­ing at boost­ing its man­u­fac­tur­ing foot­print in Eu­rope, with Ire­land as one of the coun­tries the phar­ma gi­ant is con­sid­er­ing, a spokesper­son